Tag: controlled
Pierre Fabre receives EC nod for colorectal cancer drug
Laboratoires Pierre Fabre has announced that the European Commission (EC) has approved Braftovi (encorafenib) in combination with cetuximab and FOLFOX for the first-line treatment...